Welcome to our dedicated page for Donaldson SEC filings (Ticker: DCI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating aftermarket margin trends, raw-material cost impacts, or the latest respiratory filter acquisition inside Donaldson’s sprawling disclosures can feel like sifting dust without a filter of your own. Each quarter, the company reports on three distinct segments, dozens of product lines, and global manufacturing footprints—detail that makes Donaldson (DCI) SEC filings both valuable and complex.
Stock Titan removes the clog. Our platform delivers AI-powered summaries that turn the Donaldson (DCI) annual report 10-K simplified into a clear, scrollable brief. Need the Donaldson (DCI) quarterly earnings report 10-Q filing? It arrives within minutes of hitting EDGAR, annotated with instant ratio analysis. Curious about management’s conviction? Follow Donaldson (DCI) insider trading Form 4 transactions in real time, or set alerts for every new Donaldson (DCI) Form 4 insider transactions real-time entry.
Our coverage spans all forms—8-K material events, proxy statements, S-8 equity plans—yet each is tied back to Donaldson’s filtration economics. You’ll quickly see how capital expenditures for new dust-collection lines surface in an 8-K material events explained, where executive compensation is detailed in the Donaldson (DCI) proxy statement executive compensation, and why aftermarket consumables boost free cash flow in the Donaldson (DCI) earnings report filing analysis. If you’ve wondered about understanding Donaldson (DCI) SEC documents with AI, this is your filter: comprehensive coverage, expert commentary, and real-time updates so you never miss a Donaldson (DCI) 8-K material events explained moment.
Form 144 notice of proposed sale: A shareholder filed to sell up to 7,852 shares of the issuer’s common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $645,775.77. The shares are expected to be sold on or after 10/15/2025 on the NYSE.
The shares to be sold were acquired via an option exercise on 10/15/2025 for 3,000 shares (cash), and through restricted stock vesting of 1,704 shares on 09/27/2024, 1,064 on 12/01/2022, and 2,084 on 09/22/2025. Shares outstanding were 115,907,357.
In the past three months, Andrew Dahlgren sold 3,000 common shares on 08/28/2025 for $245,879.40.
Director purchase of common stock recorded. A director reported acquiring
Insider purchase recorded: A Form 4 shows director Trudy A. Rautio bought 339 shares of Donaldson Co. (DCI) on
James J. Owens, a director of Donaldson Co., Inc. (Ticker: DCI), reported the purchase of 272 shares of the company's common stock on 10/03/2025 at a price of
Director purchase increases stake in Donaldson Co. (DCI). A Form 4 shows director Christopher M. Hilger purchased 409 shares of common stock on
Donaldson Company, Inc. is asking shareholders to vote at its virtual annual meeting on
Fiscal 2025 highlights tied to the compensation discussion show dividends of
Bradley J. Pogalz, Chief Financial Officer of Donaldson Company, reported changes in beneficial ownership on Form 4. On 10/01/2025 he exercised an employee stock option with an exercise price of $82.08 to acquire 23,900 shares of Common Stock; those shares are held directly following the transaction. The option has an expiration date of 10/01/2035 and vests in three equal annual installments beginning on October 1, 2026. The filing also discloses indirect beneficial ownership of 47 and 798 shares held by a benefit plan trust. The Form 4 was signed by Amy C. Becker as attorney-in-fact on 10/03/2025.
Richard B. Lewis, an officer (President) of DONALDSON Co. Inc. (DCI), reported several transactions on 10/01/2025–10/02/2025. He acquired 13,500 shares on 10/02/2025 at $28 per share under transaction code M, and exercised 42,100 employee stock options with an exercise price of $82.08 (transaction code A, dated 10/01/2025). Following the reported activity, he beneficially owned 53,279 shares in total, including holdings in a Benefit Plan Trust (832 and 3,866 shares listed as indirect). The filing notes the $28-strike options granted on 10/02/2025 were fully vested, while the exercised $82.08-strike option vests in three equal annual installments beginning 10/01/2026. The form is signed by an attorney-in-fact on 10/03/2025.
Bart C. Driesen, listed as President and an officer of Donaldson Co., Inc. (DCI), reported a transaction dated 10/01/2025 showing two changes in his holdings. He disposed of 5,161 shares of common stock, reducing his non‑derivative holdings, and acquired 15,300 employee stock options with an exercise price of $82.08. The options are exercisable immediately as reported, expire on 10/01/2035, and the filing states the options vest in three equal annual installments beginning on 10/01/2026. The reported ownership after the transactions shows 15,300 underlying shares from the option award held directly.
Reporting person Darcy J. DeVincke, Chief Human Resources Officer of Donaldson Co. Inc. (DCI), reported transactions dated 10/01/2025. The report shows an indirect holding of 3,863 shares of Common Stock held indirectly through a Benefit Plan Trust. It also discloses an employee stock option grant for 11,500 shares with an exercise price of $82.08, granted 10/01/2025, exercisable beginning 10/01/2026 and expiring 10/01/2035. The option vests in three equal annual installments starting on 10/01/2026. The Form 4 was signed by an attorney-in-fact and filed on 10/03/2025.